BlackRock Group’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $265K | Buy |
4,976
+275
| +6% | +$14.6K | ﹤0.01% | 2566 |
|
|
2016
Q3 | $286K | Buy |
4,701
+117
| +3% | +$7.12K | ﹤0.01% | 2488 |
|
|
2016
Q2 | $302K | Sell |
4,584
-563
| -11% | -$37.1K | ﹤0.01% | 2425 |
|
|
2016
Q1 | $292K | Buy |
5,147
+215
| +4% | +$12.2K | ﹤0.01% | 2432 |
|
|
2015
Q4 | $1.16M | Sell |
4,932
-473
| -9% | -$111K | ﹤0.01% | 1791 |
|
|
2015
Q3 | $854K | Buy |
5,405
+994
| +23% | +$157K | ﹤0.01% | 1962 |
|
|
2015
Q2 | $1.67M | Buy |
4,411
+980
| +29% | +$371K | ﹤0.01% | 1647 |
|
|
2015
Q1 | $1.43M | Buy |
3,431
+959
| +39% | +$401K | ﹤0.01% | 1648 |
|
|
2014
Q4 | $677K | Buy |
2,472
+92
| +4% | +$25.2K | ﹤0.01% | 2099 |
|
|
2014
Q3 | $463K | Sell |
2,380
-27
| -1% | -$5.25K | ﹤0.01% | 2182 |
|
|
2014
Q2 | $589K | Sell |
2,407
-1,362
| -36% | -$333K | ﹤0.01% | 2110 |
|
|
2014
Q1 | $999K | Buy |
3,769
+1,304
| +53% | +$346K | ﹤0.01% | 1964 |
|
|
2013
Q4 | $896K | Sell |
2,465
-17,600
| -88% | -$6.4M | ﹤0.01% | 1997 |
|
|
2013
Q3 | $10.7M | Sell |
20,065
-4,305
| -18% | -$2.29M | 0.01% | 903 |
|
|
2013
Q2 | $5.71M | Buy |
+24,370
| New | +$5.71M | ﹤0.01% | 958 |
|